A detailed history of Rothschild Investment LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 662 shares of VRTX stock, worth $332,621. This represents 0.02% of its overall portfolio holdings.

Number of Shares
662
Previous 686 3.5%
Holding current value
$332,621
Previous $322 Million 4.25%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$460.0 - $505.78 $11,040 - $12,138
-24 Reduced 3.5%
662 $308 Million
Q2 2024

Jul 30, 2024

BUY
$392.81 - $485.53 $269,467 - $333,073
686 New
686 $322 Million
Q1 2024

Jul 31, 2024

BUY
$407.69 - $446.08 $10,599 - $11,598
26 Added 10.83%
266 $111 Million
Q4 2023

Jul 31, 2024

SELL
$343.0 - $410.68 $152,978 - $183,163
-446 Reduced 65.01%
240 $97.7 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.